Virtual Poster Session 2

December 2, 2021

View these posters in advance, then join a LIVE Q&A with the researchers!

Aniket Wahane
Graduate student

Dual-Modality Poly‑L‑histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy

Aniket Wahane is a Ph.D. student in Dr. Bahal’s lab. He completed his Bachelor’s of Technology in Pharmaceutical Sciences from Institute of Chemical Technology, Mumbai, India and his Master’s of Science in Pharmaceutical Sciences from Northeastern University, Boston.

At Dr. Bahal’s lab, Aniket is investigating anti-sense therapy for the treatment of cancer using nanotechnology. Apart from research, he is passionate about music, soccer and computer games.
Read more . . .
Anuj Shrivastava

Prediction of percentage aggregate in a sample from DLS data using machine learning algorithm


Anuj Shrivastava is currently pursuing a PhD from Indian Institute of Technology in the Dept. of Chemical Engineering under the guidance of Prof. Anurag Rathore.

My research topic is the Analytical characterisation of biosimilar products. I did Master of Technology in Chemical engineering from the Indian Institute of Technology, Dhanbad.
Read more . . .
Anupa Anupa

Integrated Continuous Purification for Antigen-Binding Fragments (Fab) Expressed as InclusionBodies: Ranibizumab as a Case Study

Anupa is a PhD scholar at IIT Delhi, registered in the department named School of Interdisciplinary Research under the guidance of Prof. Anurag Singh Rathore.

My research interest lies in the field of downstream process development of biopharmaceuticals as well as the development of continuous processing platforms for biopharmaceuticals. The main focus on the development of continuous processing is driven by the huge cost of biopharmaceuticals such that not everyone can afford the treatment especially in the developing and under developed countries. Continuous processing has the potential to lower down the cost of these expensive biotherapeutics which interests me a lot and motivate me to do work in this field and contribute to the betterment of the society.
I have gained working experience of 2.5 years at Lupin ltd., Pune in R&D section. I was designated as Research Associate in Downstream processing department. In my industrial career, I did the process characterization of microbial based product, learned risk assessment of developing a process, designing DoE for studying the interaction between various parameters of the process.
In the academics I did my masters from Pune University (M. Sc. Biotechnology 2014-16).
I did my graduation from Gargi college, University of Delhi (B.Sc. (H) Microbiology 2011-14).
I have attended several conferences (National and International). I have won Silver Viji Award at SBCN 2021 conference, France.
I am always looking forward to grow more and excel in my field.

Read more . . .
Faisal Ibrahim, PhD

Development of Novel Stealth Non-viral vector for in vivo Delivery of siRNA to Human Lung Cancer

Faisal Ibrahim grew up in Ghana and attended The University for Development Studies, Tamale where he completed his BSc. in Applied Chemistry.

Following graduation, he moved to the United States and joined the lab of Dr. Hua Mei at the East Tennessee State University in Johnson City TN for graduate studies (2014). At the Mei’s lab, Faisal developed two new diazonium Bis(perfluoroalkyl)arylsulfonyl imide zwitterionic monomers for proton exchange membrane fuel cells. In August 2021, Faisal completed his Ph.D. in Organic Chemistry under the mentorship of Professor Michael H. Nantz at the University of Louisville, KY where he synthesized cationic lipids as siRNA delivery agents. During his Ph.D. program, he worked at the National Cancer Institute in Maryland as a predoctoral fellow and later as a postdoctoral fellow (2020-2021). In October 2021, Faisal moved to the University of Connecticut in Storrs as a Postdoctoral Research Associate to continue work on the development and formulation of cationic liposomes for siRNA delivery under the supervision of Dr. Xiuling Lu.
Read more . . .
Himanshu Malani

LC-MS based case-by-case assessment of bevacizumab charge variants on stability and bioactivity

Himanshu is a graduate student in the Department of Chemical Engineering at the Indian Institute of Technology Delhi, New Delhi working in the field of characterization of biopharmaceutical products.

Nathaly Movilla Meza

Feasibility study on the use of a closed feed frame for the development of a near infrared spectroscopic calibration model to determine low drug concentrations  

Nathaly Movilla Meza is from Barranquilla, a coast city in Colombia. In high school she was very good at Chemistry,

so she decided to study Pharmaceutical Chemistry in the University of the Atlantic in my city. In second year, she started to like he Analytical field and I knew I would like to work on something related to it. Before obtaining my degree, I began an internship in Farmacápsulas, in the quality control department. Six months later, they offered me a full-time position in the same department. For two years I also worked in the validation departments and in the regulatory affairs departments. I wanted to learn more about the analytical field, so I applied to the University of Puerto Rico, Mayaguez Campus (UPRM) to start a master’s degree in Chemistry, with a background in Analytical Chemistry. During this time, I’ve gained experience as teacher assistant, research assistant and I’ve learned about analytical techniques and instruments that were new to me. She plans to continue her graduate studies next semester and start her PhD in the same field.
Read more . . .
Nitika Nitika

Application of Raman spectroscopy for estimating critical quality attribues in protein biotheapeutics

Miss Nitika is currently a Ph.D. student in Chemical Engineering department in Indian Institute of Technology-Delhi (IIT-Delhi).

Her current work includes continuous downstream processing of Biotherapeutics protein and use of Raman spectroscopy for analytical characterisation of critical quality attributes of Biotherapeutics under the guidance of Prof. Anurag Singh Rathore. She has done her Masters from IIT-Delhi which includes molecular engineering of P. stipitis and S. cerevisiae and B.Tech from Indraprastha University where she worked on effect of Beetroot extracts on DNA degradation.
Read more . . .
Ramesh Kumar

Cyclodextrins as modulators for separation of charged variants of mAbs by capillary zone electrophoresis

Ramesh is a Ph. D student under Prof. Anurag S. Rathore at Department of Chemical Engineering, Indian Institute of Technology Delhi, India.

He completed his Masters in Biotechnology from All India Institute of Medical Sciences (AIIMS), Delhi, India and obtained Bachelor's degree in Microbiology from Swami Shraddhanand College, University of Delhi, India. My research interests include developing robust, efficient, and sensitive analytical methods to facilitate in-depth characterization of biopharmaceuticals, especially monoclonal antibodies. Currently, the majority of my work focuses on the utilization of capillary electrophoresis and liquid chromatography-based separation methods to improve the characterization of biotherapeutics.
Read more . . .
Rashmi Sharma
PhD Scholar

Optimization of the in-vitro refolding of biotherapeutic Fab Ranibizumab

Rashmi completed graduation in Biochemistry and post graduation in Genetics, both from University of Delhi.

This further led to a post doctorate in Indian Institute of Technology, Delhi, which I am currently pursuing. Her research areas include downstream processing and process development including optimisations of process steps such as refolding.
Read more . . .
Vishal Kasina

Nanoparticle-mediated delivery of miRNA mimics

Vishal Kasina is a second year PhD student in Dr. Raman Bahal's lab in the Pharmaceutics discipline at the University of Connecticut.

I earned my Bachelor's of Science in Biology from Temple University. In Dr. Bahal's lab I am researching effective methods to deliver miRNA mimics in various diseases.
Read more . . .
Vishwanath Hebbi, PhD
He has experience in process development, scale-up and development of process analytical technologies for monitoring and control of biopharmaceutical processes in manufacturing of mAbs. He has 2 years of industrial experience at Biocon Limited and completed his PhD from the Indian Institute of Technology, Delhi.
Read more . . .

These posters will not be available for the live Q&A.

Nikita Saxena

Challenges in process control for continuous processing for production of biopharmaceutical products

Nikita Saxena is Research Associate working under Prof. Anurag Rathore at Indian Institute of Technology Delhi. 


She is an expert in process control. She is presently working on a major project that involves automation and digitization of biopharma processes for continuous production of biopharmaceuticals. Her area of interest includes process integration, model-based control, statistical process control and implementation of multivariate data analytical techniques for process monitoring and control. She has published 20+ articles and a book related to control of various processes along with 2 patents filing in biopharmaceutical field.
Read more . . .
Surbhi Gupta

Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics

Surbhi Gupta, currently working on a doctoral thesis at the department of Chemical Engineering, Indian Institute of Technology, Delhi, India with the research group of Prof. Anurag S. Rathore. 

Her research areas of interest are understanding physical and chemical instabilities in Biotherapeutics, improving the stability of Biotherapeutics, and formulation studies. earlier research work includes kinetic resolution of (R,S)-flurbiprofen using immobilized lipase under the influence of the microwave irradiation with the research group of Prof. G.D. Yadav. She had completed her master's inn Bioprocess Engineering from the Institute of Chemical Technology, Mumbai, India and her undergraduate studies in Biotechnology from University School of Biotechnology, GGSIPU, Delhi, India
Read more . . .